Rua Life Sciences PLC
LSE:RUA
Rua Life Sciences PLC
LSE:RUA
Price:
10.5 GBX
Market Closed
Updated:
May 20, 2024
Section:
Relative Value
The Relative Value of one
RUA
stock under the Base Case scenario is
20.69
GBX.
Compared to the current market price of 10.5 GBX,
Rua Life Sciences PLC
is
Undervalued by 49%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RUA
Relative Value
Base Case
20.69
GBX
Undervaluation 49%
Valuation Multiples
Multiples Across Competitors
RUA Competitors Multiples
Rua Life Sciences PLC Competitors
Rua Life Sciences PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Rua Life Sciences PLC
LSE:RUA
|
6.5m GBP | 3.5 | -3.5 | -2.9 | -2.5 | |
| CH |
|
Alcon AG
SIX:ALC
|
39.5B CHF | 4.6 | 44.6 | 19.7 | 40 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.6T JPY | 8.8 | 39.8 | 24.2 | 29.9 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
191.1B DKK | 7.5 | 38.5 | 25.6 | 29.9 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
20.4B USD | 5.2 | 44.2 | 24.2 | 29.4 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
19.3B USD | 5.3 | 66.5 | 24.1 | 40.9 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.3B CNY | 14.3 | 33.8 | 29.7 | 29.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 3.1 | 50.9 | 46.8 | 50.9 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.7T KRW | 203.1 | -46.1 | -74.9 | -69.1 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.9B USD | 1.5 | -61.8 | 11.7 | 26.1 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.5B USD | 4 | 12 | 10 | 11.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
